Facial Serum Study

Study Number: C25-DP118

Study Location:

Dallas Research Center: 1801 N. Glenville Dr., Suite 250 Richardson, Texas 75081

Compensation: Up to $1000.00

Gender:

Females

Age:

55-75 years old

Skin Type:

Fitz I-VI 

Study Description:

This multicenter cosmetic clinical trial is designed to evaluate the efficacy of the Sponsor's facial serum over a 24-week treatment period (168 days), followed by a 2-week regression phase. The study involves women presenting with mild to moderate signs of aging, including forehead and marionette line wrinkles, cheek folds, tactile skin smoothness and firmness on the cheeks, lower facial jawline sagging, nasolabial folds, overall facial plumpness and radiance, and neck sagging.

Study Requirements:

Must:

✓ Have lack of firmness and sagging on face.
✓ Have dull skin.
✓ Have neck sagging.
✓ Have wrinkles on forehead, cheeks, upper lips.

Cannot:

✕ Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as lupus, Crohn’s disease, HIV, or rheumatoid arthritis).
✕ Cannot have Psoriasis, rosacea, moderate to severe acne, eczema, seborrheic dermatitis, severe excoriations on the face area.

Complete the prescreening survey below:

All information you provide will be kept confidential; you may be contacted by telephone or text. The questions in the survey will be used to determine your eligibility for our studies. If you withdraw or do not qualify, your information will be stored for future reference. You can request to have your information disabled at any time, and we will not contact you for future studies.

Screening Survey

CCPA

Not Applying? Tell Us Why